Shibuya; Masabumi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shibuya; Masabumi.The latest application filed is for "cancer cell growth inhibitor, anticancer agent, and method for screening same, as well as novel compound".

Company Profile

0.12.14

Shibuya; Masabumi - Gunma JP
Shibuya; Masabumi - Tokyo JP
Shibuya; Masabumi - Bunkyo-ku JP
Shibuya; Masabumi - Kawaguchi JP
SHIBUYA; Masabumi - Saitama JP
shibuya; Masabumi - Kawaguchi-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cancer cell growth inhibitor, anticancer agent, and method for screening same, as well as novel compound Grant 9,969,699 - Atsumi , et al. May 15, 2	2018-05-15
Cancer Cell Growth Inhibitor, Anticancer Agent, and Method for Screening Same, as well as Novel Compound App 20170291879 - Atsumi; Sonoko ; et al.	2017-10-12
Epitope Peptides Derived From Vascular Endothelial Growth Factor Receptor 1 And Vaccines Containing These Peptides App 20140186381 - Tahara; Hideaki ; et al.	2014-07-03
Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides Grant 8,663,647 - Tahara , et al. March 4, 2	2014-03-04
Epitope Peptides Derived From Vascular Endothelial Growth Factor Receptor 1 And Vaccines Containing These Peptides App 20120294877 - Tahara; Hideaki ; et al.	2012-11-22
Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides Grant 8,257,711 - Tahara , et al. September 4, 2	2012-09-04
Epitope Peptides Derived From Vascular Endothelial Growth Factor Receptor 1 And Vaccines Containing These Peptides App 20110250219 - Tahara; Hideaki ; et al.	2011-10-13
Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides Grant 7,919,099 - Tahara , et al. April 5, 2	2011-04-05
Anti-human VEGF receptor Flt-1 monoclonal antibody Grant 7,615,214 - Shitara , et al. November 10, 2	2009-11-10
Anti-human VEGF receptor Flt-1 monoclonal antibody Grant 7,615,215 - Shitara , et al. November 10, 2	2009-11-10
Epitope Peptides Derived From Vascular Endothelial Growth Factor Receptor 1 And Vaccines Containing These Peptides App 20090214581 - Tahara; Hideaki ; et al.	2009-08-27
Chimera Humanized Vascular Endothelial Growth Factor App 20080319178 - SHIBUYA; Masabumi	2008-12-25
Chimera Humanized Vascular Endothelial Growth Factor App 20080319174 - SHIBUYA; Masabumi	2008-12-25
Anti-human Vegf Receptor Flt-1 Monoclonal Antibody App 20080187529 - Shitara; Kenya ; et al.	2008-08-07
Chimeric human-type vascular endothelial cell growth factor Grant 7,405,278 - Shibuya July 29, 2	2008-07-29
Anti-human VEGF receptor FLT-1 monoclonal antibody Grant 7,052,693 - Shitara , et al. May 30, 2	2006-05-30
Anti-human VEGF receptor Flt-1 monoclonal antibody App 20060034838 - Shitara; Kenya ; et al.	2006-02-16
Anti-human VEGF receptor Flt-1 monoclonal antibody Grant 6,986,890 - Shitara , et al. January 17, 2	2006-01-17
Carboxylic acid derivative App 20050222423 - Saito, Shuji ; et al.	2005-10-06
Substance which inhibits binding of information transfer molecule for 1175-tyrosine phosphorylated KDR/Flk-1 and usages of the same App 20050004003 - Shibuya, Masabumi ; et al.	2005-01-06
Aminobenzoic acid derivatives Grant 6,720,424 - Wada , et al. April 13, 2	2004-04-13
Chimeric human-type vascular endothelial cell growth factor App 20040038341 - Shibuya, Masabumi	2004-02-26
Anti-human VEGF receptor Flt-1 monoclonal antibody App 20030088075 - Shitara, Kenya ; et al.	2003-05-08
Substance which inhibits binding of information transfer molecule for 1175-tyrosine phosphorylated KDR/FLK-1 and usages of the same App 20030022247 - Shibuya, Masabumi ; et al.	2003-01-30
VEGF-binding polypeptide Grant 6,270,993 - Shibuya , et al. August 7, 2	2001-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.